← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Equitable Holdings, Inc. (EQH) 10-Year Financial Performance & Capital Metrics

EQH • • Insurance & Managed Care
Financial ServicesDiversified InsuranceRetirement & Wealth SolutionsRetirement & Annuity Specialists
AboutEquitable Holdings, Inc., together with its consolidated subsidiaries, operates as a diversified financial services company worldwide. The company operates through four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Individual Retirement segment offers a suite of variable annuity products primarily to affluent and high net worth individuals. The Group Retirement segment provides tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities, and not-for-profit entities, as well as small and medium-sized businesses. The Investment Management and Research segment offers diversified investment management, research, and related solutions to various clients through institutional, retail, and private wealth management channels; and distributes its institutional research products and solutions. The Protection Solutions segment provides various variable universal life, indexed universal life, and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners; and a suite of life, short- and long-term disability, dental, and vision insurance products to small and medium-size businesses. The company was formerly known as AXA Equitable Holdings, Inc. and changed its name to Equitable Holdings, Inc. in January 2020. Equitable Holdings, Inc. was founded in 1859 and is based in New York, New York.Show more
  • Revenue $12.44B +18.1%
  • Combined Ratio 83.03% -10.7%
  • Net Income $1.31B +0.4%
  • Return on Equity 29.96% +0.7%
  • Medical Cost Ratio 46.93% -7.4%
  • Operating Margin 16.97% +142.1%
  • Net Margin 10.51% -15.0%
  • ROA 0.46% -7.2%
  • Equity / Assets 1.21% -35.3%
  • Book Value per Share 10.99 -25.1%
  • Tangible BV/Share -5.55 -609.7%
  • Debt/Equity 1.90 +74.1%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Profitable underwriting: 83.0% combined ratio
  • ✓Excellent 3Y average ROE of 28.3%
  • ✓Low loss ratio of 46.9%
  • ✓Share count reduced 7.6% through buybacks

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y5.27%
3Y17.77%
TTM9.34%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-9.36%
TTM-123.08%

EPS CAGR

10Y-
5Y-
3Y-
TTM-153.21%

ROCE

10Y Avg0.47%
5Y Avg0.52%
3Y Avg0.71%
Latest0.75%

Peer Comparison

Retirement & Annuity Specialists
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
AEGAegon Ltd.11.58B7.7025.6750.4%4.24%13.27%6.14%0.54
PFGPrincipal Financial Group, Inc.19.99B90.9813.6218.02%7.53%9.61%22.68%0.36
EQHEquitable Holdings, Inc.13.56B47.3112.5218.13%-5.8%-35.73%10.95%1.90
SLFSun Life Financial Inc.34.72B62.7011.90-5.15%8.54%11.91%6.88%0.65
BNTBrookfield Wealth Solutions Ltd.2.83B47.306.71106.2%9.16%7.81%100%0.35

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+10.08B11.76B12.46B12.07B9.62B12.41B7.61B12.64B10.53B12.44B
Revenue Growth %-0.17%0.06%-0.03%-0.2%0.29%-0.39%0.66%-0.17%0.18%
Medical Costs & Claims+5.75B6.09B6.95B5.46B7.49B9.51B291M5.07B5.34B5.84B
Medical Cost Ratio %----------
Gross Profit+4.33B5.67B5.51B6.61B2.13B2.9B7.32B7.58B5.19B6.6B
Gross Margin %----------
Gross Profit Growth %-0.31%-0.03%0.2%-0.68%0.36%1.52%0.03%-0.31%0.27%
Operating Expenses+3.89B3.65B4.21B4.12B4.19B4B4.71B4.59B4.45B4.49B
OpEx / Revenue %----------
Depreciation & Amortization9M758M399M296M675M1.76B519M636M812M860M
Combined Ratio %----------
Operating Income+441M2.03B1.31B2.49B-2.06B-1.09B2.61B2.99B738M2.11B
Operating Margin %----------
Operating Income Growth %-3.6%-0.36%0.91%-1.83%0.47%3.39%0.15%-0.75%1.86%
EBITDA+450M2.79B1.71B2.79B-1.39B664M3.13B3.63B1.55B2.97B
EBITDA Margin %----------
Interest Expense136M174M160M231M221M200M244M201M228M226M
Non-Operating Income-136M-174M-160M-231M-221M-200M-244M-201M-228M-226M
Pretax Income+441M2.03B1.31B2.49B-2.06B-1.09B2.61B2.99B738M2.11B
Pretax Margin %----------
Income Tax+-217M378M49M301M-593M-744M439M598M-905M288M
Effective Tax Rate %----------
Net Income+333M1.25B834M1.85B-1.76B-648M1.75B2.15B1.3B1.31B
Net Margin %----------
Net Income Growth %-2.77%-0.33%1.22%-1.95%0.63%3.71%0.23%-0.4%0%
EPS (Diluted)+0.592.241.493.27-3.51-1.56-1.245.463.483.78
EPS Growth %-2.8%-0.33%1.19%-2.07%0.56%0.21%5.4%-0.36%0.09%
EPS (Basic)0.592.241.493.27-3.51-1.56-1.245.493.493.82
Diluted Shares Outstanding561M561M561M556.5M493.6M450.4M417.4M379.9M351.6M324.8M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+205.57B216.61B235.62B220.8B249.82B275.4B292.26B252.7B276.81B295.87B
Asset Growth %-0.05%0.09%-0.06%0.13%0.1%0.06%-0.14%0.1%0.07%
Total Investment Assets+66.08B73.56B83.01B81.33B93.34B108.09B105.11B93.1B74.69B161.66B
Long-Term Investments53.2B58.63B66.62B65.67B77.11B102.54B85.45B71.49B7.66B85.02B
Short-Term Investments39.89B41.88B46.94B16.02B66.34B5.55B78.22B63.36B67.03B76.64B
Total Current Assets+28.13B70.51B73.65B381M07.93B0028.2B1.63B
Cash & Equivalents6.56B5.65B4.81B4.47B4.41B6.18B5.19B4.28B8.24B6.96B
Receivables1000K1000K1000K01000K1000K1000K1000K1000K1000K
Other Current Assets015.65B14.71B0-77.33B-10.59B-100.68B-79.23B-59.3B-93.98B
Goodwill & Intangibles+5.24B5.24B4.82B4.78B4.75B4.74B4.73B5.48B5.43B5.37B
Goodwill4.74B4.94B4.57B004.6B005.14B5.14B
Intangible Assets507M487M416M00140M00289M230M
PP&E (Net)00000691M00516M618M
Other Assets160.29B166.23B181.76B121.8B-81.86B-14.15B-90.18B-76.97B229.71B-618M
Total Liabilities191.99B201.61B218.47B205.18B234.41B258.08B278.7B249.11B271.66B292.3B
Total Debt+6.45B4.51B6.03B4.96B4.11B5.28B5.12B5.23B5.63B6.78B
Net Debt-106M-1.15B1.22B486M-294M-1.75B-66M950M-2.61B-1.01B
Long-Term Debt4.33B2.88B3.08B4.41B4.11B4.43B5.03B4.47B5.38B5.95B
Short-Term Debt4.8B1.63B2.95B546M0207M92M759M254M137M
Total Current Liabilities+7.03B8.4B8.24B6.18B018.17B005.14B4.12B
Accounts Payable3.66B4.41B4.45B4.96B4.65B2.82B6.26B5.57B2.68B4.12B
Deferred Revenue0000000000
Other Current Liabilities02.36B840M605M-4.65B15.13B-6.36B-6.33B2.2B-238M
Deferred Taxes00001000K1000K0000
Other Liabilities180.63B189.45B207.15B194.59B-4.64B235.05B-5.03B-4.47B253.59B266.82B
Total Equity+13.58B15B17.14B15.62B15.41B17.32B13.56B3.6B5.16B3.57B
Equity Growth %-0.1%0.14%-0.09%-0.01%0.12%-0.22%-0.73%0.43%-0.31%
Shareholders Equity10.44B11.46B13.42B13.87B13.46B15.58B11.52B1.4B2.65B1.58B
Minority Interest3.14B3.54B3.72B1.75B1.96B1.74B2.04B2.19B2.51B1.98B
Retained Earnings10.16B11.44B12.22B13.99B11.74B10.7B8.88B9.82B10.24B10.65B
Common Stock06M5M5M5M5M4M4M5M5M
Accumulated OCI-677M-921M-108M-1.4B844M3.86B2B-8.99B-7.78B-8.71B
Return on Equity (ROE)0.02%0.09%0.05%0.11%-0.11%-0.04%0.11%0.25%0.3%0.3%
Return on Assets (ROA)0%0.01%0%0.01%-0.01%-0%0.01%0.01%0%0%
Equity / Assets----------
Debt / Equity0.47x0.30x0.35x0.32x0.27x0.31x0.38x1.45x1.09x1.90x
Book Value per Share24.2126.7430.5628.0731.2238.4532.499.4714.6710.99
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-192M-236M-243M61M-216M-61M-193M-250M-208M1.64B
Operating CF Growth %--0.23%-0.03%1.25%-4.54%0.72%-2.16%-0.3%0.17%8.88%
Operating CF / Revenue %----------
Net Income658M1.65B1.26B2.15B-1.47B-349M388M2.39B1.3B1.31B
Depreciation & Amortization9M-21M399M296M675M1.76B519M636M812M0
Stock-Based Compensation243M213M247M228M278M210M274M328M-144M0
Deferred Taxes0000000000
Other Non-Cash Items-1.27B-2.33B-2.78B-2.17B728M-1.79B983M-2.22B434M1.99B
Working Capital Changes169M254M637M-448M-430M110M-2.36B-1.39B-2.61B-1.66B
Cash from Investing+-2.14B-5.77B-9.69B-2.05B-8.5B-7.82B-12.69B-7.49B-4.85B-15.36B
Capital Expenditures-83M-97M-102M-123M-93M-107M-120M-167M-117M-153M
Acquisitions0-21M-130M-472M0219M040M0340M
Purchase of Investments-27.19B-24.99B-33.39B-29.25B-34.46B-30.31B-51.34B-21.33B-18.03B-31.25B
Sale/Maturity of Investments1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Investing-78M-709M1.36B978M-627M-1.44B-1.68B-3.05B-1.97B795M
Cash from Financing+2.9B5.11B9.07B1.66B8.71B9.67B11.95B7.04B9B12.1B
Dividends Paid000-157M-285M-350M-375M-374M-381M-382M
Share Repurchases-214M-236M-275M-2.25B-1.52B-579M-1.9B-1.06B-1.06B-1.26B
Stock Issued0000775M494M293M000
Debt Issuance (Net)-1000K-1000K1000K1000K-1000K1000K1000K-1000K1000K-1000K
Other Financing3.51B6.97B8.61B3.01B10.1B9.81B13.32B8.54B9.54B14.55B
Net Change in Cash+555M-903M-840M-345M-64M1.77B-991M-907M3.96B-1.64B
Exchange Rate Effect-1000K-1000K1000K-1000K-1000K-1000K-1000K-1000K1000K-1000K
Cash at Beginning6B6.56B5.65B4.81B4.47B4.41B6.18B5.19B4.28B9.11B
Cash at End6.56B5.65B4.81B4.47B4.41B6.18B5.19B4.28B8.24B7.46B
Free Cash Flow+-275M-333M-345M-62M-309M-168M-313M-417M-325M1.49B
FCF Growth %--0.21%-0.04%0.82%-3.98%0.46%-0.86%-0.33%0.22%5.57%
FCF Margin %----------
FCF per Share-0.49-0.59-0.61-0.11-0.63-0.37-0.75-1.1-0.924.57

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio95.62%82.77%89.52%79.37%121.42%108.8%65.73%76.34%92.99%83.03%
Medical Cost Ratio57.07%51.76%55.74%45.23%77.84%76.62%3.82%40.06%50.68%46.93%
Return on Equity (ROE)2.45%8.77%5.19%11.32%-11.37%-3.96%11.37%25.09%29.75%29.96%
Return on Assets (ROA)0.16%0.59%0.37%0.81%-0.75%-0.25%0.62%0.79%0.49%0.46%
Equity / Assets6.61%6.92%7.28%7.07%6.17%6.29%4.64%1.42%1.86%1.21%
Book Value / Share24.2126.7430.5628.0731.2238.4532.499.4714.6710.99
Debt / Equity0.47x0.30x0.35x0.32x0.27x0.31x0.38x1.45x1.09x1.90x
Revenue Growth-16.71%5.93%-3.14%-20.3%29.07%-38.67%66.06%-16.74%18.13%

Revenue by Segment

2018201920202021202220232024
Investment Advice439M104M113M126M134M160M166M
Investment Advice Growth--76.31%8.65%11.50%6.35%19.40%3.75%
Investment Advisory, Management and Administrative Service4.25B------
Investment Advisory, Management and Administrative Service Growth-------
Asset Management2.88B------
Asset Management Growth-------
Distribution Service723M------
Distribution Service Growth-------
Service, Other479M------
Service, Other Growth-------
Investment Performance118M------
Investment Performance Growth-------
Shareholder Service76M------
Shareholder Service Growth-------
Financial Service, Other19M------
Financial Service, Other Growth-------

Frequently Asked Questions

Valuation & Price

Equitable Holdings, Inc. (EQH) has a price-to-earnings (P/E) ratio of 12.5x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Equitable Holdings, Inc. (EQH) grew revenue by 18.1% over the past year. This is strong growth.

Equitable Holdings, Inc. (EQH) reported a net loss of $696.0M for fiscal year 2024.

Dividend & Returns

Yes, Equitable Holdings, Inc. (EQH) pays a dividend with a yield of 1.97%. This makes it attractive for income-focused investors.

Equitable Holdings, Inc. (EQH) has a return on equity (ROE) of 30.0%. This is excellent, indicating efficient use of shareholder capital.

Industry Metrics

Equitable Holdings, Inc. (EQH) has a combined ratio of 83.0%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.